NIH-funded research U01 cooperative agreement

Understanding different biological responses in patients with acute respiratory distress syndrome.

Official title: The MUltidimenSional phenotyping In Critical care (MUSIC) Consortium: A pathway to precision medicine at the bedside

Funded at Vanderbilt University Medical Center · NIH-11085917 · Data updated 2026-11-12

This study is looking at how to better understand and group patients with acute respiratory distress syndrome (ARDS) based on their unique biological responses, so that doctors can create more personalized treatments that work best for each individual.

More Critical Care research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startMay 1, 2023
Project endApril 30, 2029
Funding year2025
Award (this year)$574,036
NIH project number5U01HL168412-03
Project IDNIH-11085917 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults diagnosed with acute respiratory distress syndrome or related critical illnesses.

Less likely to help

Patients with chronic respiratory conditions or those not experiencing acute respiratory distress may not benefit from this research.

What this research studies

This research investigates how patients with acute respiratory distress syndrome (ARDS) can be better classified based on their unique biological responses, which can lead to more personalized treatments. By analyzing large groups of patients, the study aims to identify specific phenotypes, or biological characteristics, that influence how patients respond to various therapies. The research will involve collecting data from a significant number of critically ill patients to understand their long-term outcomes and improve treatment strategies. This approach seeks to move beyond traditional classifications to develop targeted therapies that are tailored to individual patient needs.

Why it matters

Potential benefit: If successful, this research could lead to more effective, personalized treatments for patients suffering from acute respiratory distress syndrome.

How similar studies have gone: Previous research has shown promise in using biological phenotyping to improve treatment outcomes in critical illnesses, suggesting that this approach could be effective.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Ware, Lorraine B — Vanderbilt University Medical Center
  • Study coordinator: Ware, Lorraine B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.